CANOPY GROWTH CORP

Insider Selling Quietly Continues as Canopy Growth Pursues Restructuring and Capital Discipline

Insider selling at Canopy Growth shows a neutral, liquidity‑focused trend amid restructuring, indicating cautious portfolio moves rather than confidence loss.

CANOPY GROWTH CORP
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

30/09/2026, 22:47

3 minutes to read

Canopy Growth CEO Mongeau Offloads 9,376 Shares as Stock Slides 6% This Week, Investors Question Insider Confidence

Canopy Growth CEO sells 9,376 shares—insider sale amid market dip reveals liquidity moves, not bearish outlook, and highlights MTL Cannabis expansion prospects.

CANOPY GROWTH CORP
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

13/02/2026, 02:09

2 minutes to read